Drug Profile
NSC 639366
Alternative Names: SPC 100097Latest Information Update: 14 Mar 2008
Price :
$50
*
At a glance
- Originator Nonindustrial source; Research Triangle Park Laboratories
- Class Anthraquinones; Antineoplastics; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Apr 2001 Sphinx Pharmaceuticals is now called Sphinx Laboratories